首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   182篇
  免费   12篇
  国内免费   12篇
耳鼻咽喉   1篇
儿科学   5篇
基础医学   10篇
口腔科学   4篇
临床医学   24篇
内科学   51篇
皮肤病学   1篇
神经病学   13篇
特种医学   62篇
外科学   8篇
综合类   6篇
预防医学   7篇
眼科学   1篇
药学   8篇
肿瘤学   5篇
  2021年   1篇
  2018年   3篇
  2017年   2篇
  2016年   4篇
  2015年   6篇
  2014年   3篇
  2013年   6篇
  2011年   3篇
  2010年   5篇
  2009年   5篇
  2008年   8篇
  2007年   15篇
  2006年   2篇
  2005年   7篇
  2004年   1篇
  2003年   5篇
  2002年   5篇
  2000年   2篇
  1999年   1篇
  1998年   7篇
  1997年   7篇
  1996年   11篇
  1995年   5篇
  1994年   16篇
  1993年   16篇
  1992年   4篇
  1991年   2篇
  1990年   2篇
  1989年   8篇
  1988年   8篇
  1987年   10篇
  1986年   1篇
  1985年   1篇
  1984年   2篇
  1981年   1篇
  1980年   5篇
  1979年   2篇
  1978年   1篇
  1977年   1篇
  1976年   5篇
  1975年   2篇
  1974年   2篇
  1973年   2篇
  1971年   1篇
排序方式: 共有206条查询结果,搜索用时 15 毫秒
31.
32.
33.
34.
Obioactin, Lonomycin A, muramyl dipeptide, and scavengers of hydrogen radicals and of singlet oxygen were used to study the participation of ·OH and1O2 in the killing ofToxoplasma in cultures of glycogen-induced peritoneal macrophages. Both the scavengers of OH (diazabicyclooctane and histidine) and those of1O2 (mannitol and sodium benzoate) failed to inhibit the multiplication ofToxoplasma in macrophages that were incubated with either Obioactin, Lonomycin A, or MDP. The results of these experiments demonstrate the apparent lack of an inhibitory effect of ·OH and1O2 on the multiplication ofToxoplasma, whereas the scavengers alone inhibited the growth of the parasites.  相似文献   
35.
36.
37.
Immigrants may be carriers of infectious diseases because of the prevalence of these diseases in their country of origin, exposure during migration, or conditions during resettlement, with this prevalence being particularly high in sub-Saharan Africans. We performed a retrospective review of 180 sub-Saharan immigrants screened for infectious diseases at an International Health Center from January 2009 to December 2012. At least one pathogenic infectious disease was diagnosed in 72.8% patients: 60.6% latent tuberculosis infection, 36.8% intestinal parasites (intestinal protozoa or helminths), 28.1% helminths, 14.8% hepatitis B surface antigen positive, 1.2% anti-hepatitis C virus positive, 1.2% human immunodeficiency virus–positive, and 1.2% malaria. Coinfections were present in 28.4%. There was significant association between eosinophilia (absolute count or percentage) or hyper-IgE and the presence of helminths (P < 0.001). Relative eosinophilia and hyper-IgE were better indicators of helminth infection than absolute eosinophilia, particularly for schistosomiasis and strongyloidiasis. We found a high prevalence of infectious diseases in sub-Saharan immigrants, which could lead to severe health problems (in the absence of prompt treatment), representing a high cost to the public health system and possible transmission in the host country. Accurate screening and tailored protocols for infectious diseases are recommended in sub-Saharan immigrants.  相似文献   
38.
39.
40.
The clinical significance of interleukin 2 receptor (IL2R) concentrations in serum was determined for 344 children with newly diagnosed acute lymphoblastic leukemia (ALL). Serum levels of IL2R in patients (267 to 80,000 U/mL, median 2,007 U/mL) were significantly higher than normal control values (170 to 738 U/mL, median 347 U/mL) (P less than .0001). Measurements in cases of T cell ALL were lower than in the non-T, non-B cases (P = .02). Among the 264 patients with non-T, non-B ALL, but not in those with T cell disease, higher serum IL2R levels (greater than 2,000 U/mL) were associated with a poorer treatment outcome (P = .04). In a multivariate analysis, serum IL2R level contributed independent prognostic information beyond that conveyed by leukocyte count, race, and age (P = .04). One explanation for these results is that soluble IL2R competes with normal lymphocyte- integrated IL2R for the ligand and thus could suppress host antitumor immunity.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号